» Articles » PMID: 38541732

Extracellular Vesicles As Next-Generation Biomarkers in Lung Cancer Patients: A Case Report on Adenocarcinoma and Squamous Cell Carcinoma

Abstract

Extracellular vesicles (EVs) released from primary cell lines, originating from resected tissues during biopsies in patients with non-small cell lung cancer (NSCLC) revealing adenocarcinoma and squamous cell carcinoma subtypes, were examined for membrane proteomic fingerprints using a proximity barcoding assay. All the collected EVs expressed canonical tetraspanins (CD9, CD63, and CD81) highly coexpressed with molecules such as lysosome-associated membrane protein-1 (LAMP1-CD107a), sialomucin core protein 24 (CD164), Raph blood group (CD151), and integrins (ITGB1 and ITGA2). This representation of the protein molecules on the EV surface may provide valuable information on NSCLC subtypes and offer new diagnostic opportunities as next-generation biomarkers in personalized oncology.

Citing Articles

The latest advances in liquid biopsy for lung cancer-a narrative review.

She W, Garitaonaindia Y, Lin Y Transl Lung Cancer Res. 2024; 13(11):3241-3251.

PMID: 39669995 PMC: 11632431. DOI: 10.21037/tlcr-24-828.


Wildfire-relevant woodsmoke and extracellular vesicles (EVs): Alterations in EV proteomic signatures involved in extracellular matrix degradation and tissue injury in airway organotypic models.

Vitucci E, Carberry C, Payton A, Herring L, Mordant A, Kim Y Environ Res. 2024; 264(Pt 2):120395.

PMID: 39571711 PMC: 11694228. DOI: 10.1016/j.envres.2024.120395.


Nanoscale Extracellular Vesicle-Enabled Liquid Biopsy: Advances and Challenges for Lung Cancer Detection.

Khan A, Raza F, He N Micromachines (Basel). 2024; 15(10).

PMID: 39459055 PMC: 11509190. DOI: 10.3390/mi15101181.


Surface-Bioengineered Extracellular Vesicles Seeking Molecular Biotargets in Lung Cancer Cells.

Kowalczyk A, Dziubak D, Kasprzak A, Sobczak K, Ruzycka-Ayoush M, Bamburowicz-Klimkowska M ACS Appl Mater Interfaces. 2024; 16(25):31997-32016.

PMID: 38869318 PMC: 11212023. DOI: 10.1021/acsami.4c04265.

References
1.
Karhemo P, Hyvonen M, Laakkonen P . Metastasis-associated cell surface oncoproteomics. Front Pharmacol. 2012; 3:192. PMC: 3491318. DOI: 10.3389/fphar.2012.00192. View

2.
Su C, Li J, Zhang L, Wang H, Wang F, Tao Y . The Biological Functions and Clinical Applications of Integrins in Cancers. Front Pharmacol. 2020; 11:579068. PMC: 7522798. DOI: 10.3389/fphar.2020.579068. View

3.
Hallal S, Tuzesi A, Grau G, Buckland M, Alexander K . Understanding the extracellular vesicle surface for clinical molecular biology. J Extracell Vesicles. 2022; 11(10):e12260. PMC: 9563386. DOI: 10.1002/jev2.12260. View

4.
Ranjbar M, Jamshidi M . Overexpression of Lysosome-Associated Membrane Protein 1 in Oral Squamous Cell Carcinoma and its Correlation with Tumor Differentiation and Metastasis. Iran J Otorhinolaryngol. 2022; 34(120):3-8. PMC: 8801010. DOI: 10.22038/IJORL.2021.51683.2772. View

5.
Li Y, Sun C, Tan Y, Zhang H, Li Y, Zou H . ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition. Int J Biol Sci. 2021; 17(2):635-650. PMC: 7893583. DOI: 10.7150/ijbs.52319. View